S&P: Novant unchanged

Standard & Poor's said that Novant Health Inc.'s planned acquisition of MedQuest Inc. and parent MQ Associates is not likely to affect its AA- rating or stable outlook on Novant Health's debt.

At the same time, S&P said it placed its B- rating on MedQuest and parent MQ Associates' debt on CreditWatch with positive implications.

"This acquisition is a key part of Novant's ambulatory strategy, recognizing that imaging services often provide a catalyst for medical group expansion," said S&P credit analyst Kenneth W. Rodgers.

"We expect to meet with Novant's management sometime this fall after the deal closes to more fully assess the effect of this transaction and to review the health system's current and projected financial results."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.